The clinical relevance of antibodies to ribosomal P—where are we now?
- 作者Robin A. Fox; David A. Isenberg
- 卷第7卷
- 期第4期
- 印刷ISSN1439-7595
- 电子ISSN1439-7609
- 文件大小575.15KB
- 发表时间1997-12
- DOI10.1007/bf03041326
- 页码235-245
Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behçet's diseaseMitsuhiro Takeno; Yoshihiro Shimoyama; Jun-Ichi Kashiwakura; Hiroko Nagafuchi; Tsuyoshi Sakane; Noboru Suzuki · 2004
Methyl-vitamin B12 blocks the CD28 co-stimulatory pathway in human T cells and its possible therapeutic application for T cell-mediated diseases, including rheumatoid arthritisNagafuchi, Hiroko; Suzuki, Noboru; Takeno, Mitsuhiro; Sakane, Tsuyoshi · Japanese Journal of Rheumatology · 1997
Fine antigen specificity of human γδ T cell lines (Vγ9+) established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Streptococcus sanguisMitsuru Mochizuki; Noboru Suzuki; Mitsuhiro Takeno; Hiroko Nagafuchi; Tatsuhiro Harada; Hidetoshi Kaneoka; Naomi Yamashita; Kenji Hirayama; Toshiharu Nakajima; Yutaka Mizushima; Shoso Yamamoto; Tsuyoshi Sakane · 1994